The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force
Abstract The number of available therapies for rare diseases remains low, as fewer than 6% of rare diseases have an approved treatment option. The International Rare Diseases Research Consortium (IRDiRC) set up the multi-stakeholder Data Mining and Repurposing (DMR) Task Force to examine the potenti...
Main Authors: | Noel T Southall, Madhusudan Natarajan, Lilian Pek Lian Lau, Anneliene Hechtelt Jonker, Benoît Deprez, Tim Guilliams, Lawrence Hunter, Carin MA Rademaker, Virginie Hivert, Diego Ardigò, on behalf of the IRDiRC Data Mining and Repurposing Task Force |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-019-1193-3 |
Similar Items
-
Recommendations from the IRDiRC Working Group on methodologies to assess the impact of diagnoses and therapies on rare disease patients
by: Galliano Zanello, et al.
Published: (2022-05-01) -
How to START? Four pillars to optimally begin your orphan drug development
by: Anneliene Hechtelt Jonker, et al.
Published: (2023-08-01) -
Essential list of medicinal products for rare diseases: recommendations from the IRDiRC Rare Disease Treatment Access Working Group
by: William A. Gahl, et al.
Published: (2021-07-01) -
Towards the international interoperability of clinical research networks for rare diseases: recommendations from the IRDiRC Task Force
by: Rima Nabbout, et al.
Published: (2023-05-01) -
Measuring what matters to rare disease patients – reflections on the work by the IRDiRC taskforce on patient-centered outcome measures
by: Thomas Morel, et al.
Published: (2017-11-01)